252 related articles for article (PubMed ID: 29679849)
1. Global analysis of advanced/metastatic breast cancer: Decade report (2005-2015).
Cardoso F; Spence D; Mertz S; Corneliussen-James D; Sabelko K; Gralow J; Cardoso MJ; Peccatori F; Paonessa D; Benares A; Sakurai N; Beishon M; Barker SJ; Mayer M
Breast; 2018 Jun; 39():131-138. PubMed ID: 29679849
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey.
Brufsky AM; Ormerod C; Bell Dickson R; Citron ML
Breast J; 2017 Jan; 23(1):17-25. PubMed ID: 27623209
[TBL] [Abstract][Full Text] [Related]
3. Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey.
Bonotto M; Basile D; Gerratana L; Pelizzari G; Bartoletti M; Vitale MG; Fanotto V; Lisanti C; Mansutti M; Minisini AM; Aprile G; De Laurentiis M; Montemurro F; Del Mastro L; Puglisi F
Breast; 2018 Aug; 40():45-52. PubMed ID: 29679936
[TBL] [Abstract][Full Text] [Related]
4. Outcomes research examining treatments, quality of life and costs in HER2-negative and triple-negative metastatic breast cancer: a systematic literature review.
Parisi M; Pelletier C; Cherepanov D; Broder MS
J Comp Eff Res; 2018 Jan; 7(1):67-83. PubMed ID: 29303361
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Outcome Measures to Improve the Care Continuum for Patients With Metastatic Breast Cancer: Opportunities and Implications for Nursing Practice.
de Ligt KM; de Rooij BH; Koppert LB; van de Poll-Franse LV; Velikova G; Cardoso F
Semin Oncol Nurs; 2023 Dec; 39(6):151510. PubMed ID: 37833113
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.
Foster TS; Miller JD; Boye ME; Blieden MB; Gidwani R; Russell MW
Cancer Treat Rev; 2011 Oct; 37(6):405-15. PubMed ID: 21477928
[TBL] [Abstract][Full Text] [Related]
7. Re-imagining metastatic breast cancer care delivery: a patient-partnered qualitative study.
Roberson ML; Henricks A; Woods J; Glenn L; Maues J; James D; Reid S
Support Care Cancer; 2023 Nov; 31(12):735. PubMed ID: 38055111
[TBL] [Abstract][Full Text] [Related]
8. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
9. Living with metastatic breast cancer (LIMBER): experiences, quality of life, gaps in information, care and support of patients in the UK.
Fallowfield L; Starkings R; Palmieri C; Tait A; Stephen L; May S; Habibi R; Russ S; Shilling V; Jenkins V
Support Care Cancer; 2023 Jul; 31(8):459. PubMed ID: 37432501
[TBL] [Abstract][Full Text] [Related]
10. Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey.
Thrift-Perry M; Cabanes A; Cardoso F; Hunt KM; Cruz TA; Faircloth K
Breast; 2018 Oct; 41():93-106. PubMed ID: 30025274
[TBL] [Abstract][Full Text] [Related]
11. Exploring Unmet Needs from an Online Metastatic Breast Cancer Support Group: A Qualitative Study.
Kadravello A; Tan SB; Ho GF; Kaur R; Yip CH
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356974
[No Abstract] [Full Text] [Related]
12. Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study.
Lee Mortensen G; Madsen IB; Krogsgaard R; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):146-151. PubMed ID: 29202668
[TBL] [Abstract][Full Text] [Related]
13. Cost of illness associated with metastatic breast cancer.
Rao S; Kubisiak J; Gilden D
Breast Cancer Res Treat; 2004 Jan; 83(1):25-32. PubMed ID: 14997052
[TBL] [Abstract][Full Text] [Related]
14. Indirect costs associated with metastatic breast cancer.
Wan Y; Gao X; Mehta S; Wang Z; Faria C; Schwartzberg L
J Med Econ; 2013 Oct; 16(10):1169-78. PubMed ID: 23866016
[TBL] [Abstract][Full Text] [Related]
15. Supporting Kenyan women with advanced breast cancer through a network and assessing their needs and quality of life.
Shaikh AJ; Dhillion N; Shah J; Kathomi C; Kiragu A; Asirwa FC; Nyongesa C; Kasmani R; Abayo I; Kirathe G; Sayed S
Support Care Cancer; 2022 Feb; 30(2):1557-1567. PubMed ID: 34537888
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).
Williamson TJ; Love SM; Clague DeHart JN; Jorge-Miller A; Eshraghi L; Cooper Ortner H; Stanton AL
Breast Cancer Res Treat; 2018 Aug; 171(1):75-84. PubMed ID: 29767345
[TBL] [Abstract][Full Text] [Related]
17. Bridging gaps, expanding outreach: Metastatic Breast Cancer Advocacy Working Group Consensus Report. January 25, 2008.
MBC Advocacy Working Group
Breast; 2009 Oct; 18(5):273-5. PubMed ID: 19616435
[TBL] [Abstract][Full Text] [Related]
18. Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer.
Başaran GA; Twelves C; Diéras V; Cortés J; Awada A
Cancer Treat Rev; 2018 Feb; 63():144-155. PubMed ID: 29329006
[TBL] [Abstract][Full Text] [Related]
19. Unmet needs and problems related to employment and working as reported by survivors with metastatic breast cancer.
Sesto ME; Carroll CB; Zhang X; Chen KB; Terhaar A; Wilson AS; Tevaarwerk AJ
Support Care Cancer; 2022 May; 30(5):4291-4301. PubMed ID: 35088147
[TBL] [Abstract][Full Text] [Related]
20. A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada.
Beauchemin C; Letarte N; Mathurin K; Yelle L; Lachaine J
J Med Econ; 2016 Jun; 19(6):619-29. PubMed ID: 26850287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
